# Riboflavin for Glutamate Reduction in Alcohol Withdrawal

> **NCT04232800** · PHASE2 · UNKNOWN · sponsor: **Oregon Health and Science University** · enrollment: 40 (estimated)

## Conditions studied

- Alcohol Withdrawal
- Nutrition Disorders
- Alcohol Use Disorder

## Interventions

- **DRUG:** Riboflavin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04232800
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2022-08-25
- **Final completion:** 2022-10-25
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04232800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04232800, "Riboflavin for Glutamate Reduction in Alcohol Withdrawal". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT04232800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*